 | Up a level |
Bachert, C., Moesges, R., Virchow, J. C., Wahn, U., Kuhl, H. C. and Klimek, L. (2015). MP29-02*provides effective AR symptom control in real life in all patient types regardless of predominant nasal symptom or presence of ocular symptoms: results from Germany. Allergy, 70. S. 505 - 506. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995
Virchow, J. C., Klimek, L., Wahn, U., Moesges, R., Kuhl, H. C. and Bachert, C. (2015). MP29-02*provides effective AR symptom control in real life in previous or potential treatment failure patients: results from Germany. Allergy, 70. S. 503 - 505. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995
Wahn, U., Bachert, C., Virchow, J. C., Moesges, R., Kuhl, H. C. and Klimek, L. (2015). MP29-02*provides effective AR symptom control in real life regardless of number of previous clinic visits: results from Germany. Allergy, 70. S. 499 - 500. HOBOKEN: WILEY. ISSN 1398-9995